Company intelligence / Profile preview

BestHealth4U

Ownership: Private
Development stage: Preclinical

Overview

BestHealth4U is pioneering sustainable, advanced biomaterial solutions for skin-interacting medical devices. Their technologies aim to prevent skin injuries, accelerate wound healing, and improve patient outcomes. The company has received significant EU funding (€4.25M) to establish manufacturing capabilities and complete clinical validation of its lead products.[1][2][3][4] Roche has expressed interest in supporting the pilot project for their Bio2Skin pre-eclampsia diagnostic sensor if clinically validated.[1]

Therapeutic areas: DermatologyWomen's Health
Modalities: Advanced biomaterials for skin-interacting medical devicesMedical adhesivesDiagnostic sensors (e.g., pre-eclampsia sensor)
Industry: Consumable Medical Devices

Partnerships

Roche (potential partnership pending product validation)[1]Patient organizations and hospitals worldwide[2]

Beyond the preview

Go deeper on BestHealth4U.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BestHealth4U.

Explore the full profile